Anales RANF

Aida Menéndez Méndez, Juan Ignacio Díaz Hernández, Felipe Ortega, Rosa Gómez Villafuertes, Javier Gualix @Real Academia Nacional de Farmacia. Spain 196 and its role in the ATP release, in the complex interplay among extracellular ATP, purinergic receptors and microglial cells in the context of neuroinflammatory responses in neurodegenerative diseases. 6. ACKNOWLEDGEMENTS This work was funded by the Spanish Ministerio de Economía y Competitividad (BFU 2014-53654-P), by the Comunidad de Madrid (BRADE-CM S2013/ICE-2958) and by Fundación Ramón Areces research funding (PR2018/16-02). FO acknowledges the Ramon y Cajal Program of the Spanish Ministry of Economy and Competitiveness (RYC-2013-13290). 7. REFERENCES 1. Kettenmann H, Hanisch UK, Noda M , et al. Physiology of Microglia . Physiological Reviews 2011; 91: 461-553. 2. Frenkel D, Wilkinson K, Zhao LZ , et al. Scara1 deficiency impairs clearance of soluble amyloid-beta by mononuclear phagocytes and accelerates Alzheimer's-like disease progression . Nature Communications 2013; 4. 3. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice . Journal of Neuroscience 2008; 28: 8354-60. 4. Michaud JP, Halle M, Lampron A , et al. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology . Proceedings of the National Academy of Sciences of the United States of America 2013; 110: 1941-6. 5. Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease . Nature Reviews Neuroscience 2015; 16: 358-72. 6. Heneka MT, Carson MJ, El Khoury J , et al. Neuroinflammation in Alzheimer's disease . Lancet Neurology 2015; 14: 388-405. 7. Abbracchio MP, Burnstock G, Boeynaems JM , et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy . Pharmacol Rev 2006; 58: 281-341. 8. North RA. Molecular physiology of P2X receptors . Physiological Reviews 2002; 82: 1013-67. 9. Koizumi S, Ohsawa K, Inoue K , et al. Purinergic receptors in microglia: Functional modal shifts of microglia mediated by P2 and P1 receptors . Glia 2013; 61: 47-54. 10. Domercq M, Vazquez-Villoldo N, Matute C. Neurotransmitter signaling in the pathophysiology of microglia . Frontiers in Cellular Neuroscience 2013; 7. 11. Ohsawa K, Kohsaka S. Dynamic Motility of Microglia: Purinergic Modulation of Microglial Movement in the Normal and Pathological Brain . Glia 2011; 59: 1793-9. 12. Bianco F, Fumagalli M, Pravettoni E , et al. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia . Brain Research Reviews 2005; 48: 144-56. 13. Lister MF, Sharkey J, Sawatzky DA , et al. The role of the purinergic P2X7 receptor in inflammation . J Inflamm (Lond) 2007; 4: 5. 14. Matute C, Torre I, Perez-Cerda F , et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis . J Neurosci 2007; 27: 9525-33. 15. Xiang Z, Burnstock G. Changes in expression of P2X purinoceptors in rat cerebellum during postnatal development . Brain Res Dev Brain Res 2005; 156: 147-57. 16. Monif M, Reid CA, Powell KL , et al. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore . J Neurosci 2009; 29: 3781-91. 17. Weisman GA, Camden JM, Peterson TS , et al. P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y(2) receptor interactions in neuroinflammation . Mol Neurobiol 2012; 46: 96-113. 18. Ferrari D, Pizzirani C, Adinolfi E , et al. The P2X7 receptor: a key player in IL-1 processing and release . J Immunol 2006; 176: 3877-83. 19. Arulkumaran N, Unwin RJ, Tam FW. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases . Expert Opin Investig Drugs 2011; 20: 897-915. 20. Friedle SA, Curet MA, Watters JJ. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation . Recent Pat CNS Drug Discov 2010; 5: 35-45. 21. Leon-Otegui M, Gomez-Villafuertes R, Diaz- Hernandez JI , et al. Opposite effects of P2X7 and P2Y2 nucleotide receptors on alpha-secretase- dependent APP processing in Neuro-2a cells . FEBS Lett 2011; 585: 2255-62. 22. Diaz-Hernandez JI, Gomez-Villafuertes R, Leon- Otegui M , et al. In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases . Neurobiol Aging 2012; 33: 1816-28. 23. Dou Y, Wu HJ, Li HQ , et al. Microglial migration mediated by ATP-induced ATP release from lysosomes . Cell Res 2012; 22: 1022-33. 24. Liu GJ, Kalous A, Werry EL , et al. Purine release from spinal cord microglia after elevation of calcium by glutamate . Mol Pharmacol 2006; 70: 851-9. 25. Ma Y, Cao W, Wang L , et al. Basal CD38/cyclic ADP-ribose-dependent signaling mediates ATP release and survival of microglia by modulating connexin 43 hemichannels . Glia 2014; 62: 943-55.